ENSG00000197323 |
|
hemangioblastoma |
sequence_alteration |
28.12% (9/32) |
1 entry |
ENSG00000197323 |
|
prostate adenocarcinoma |
missense_variant |
4.952% (72/1454) |
2 entries |
ENSG00000197323 |
|
breast ductal adenocarcinoma |
sequence_alteration |
10.28% (67/652) |
1 entry |
ENSG00000197323 |
|
papillary thyroid carcinoma |
gene_fusion |
49.38% (79/160) |
2 entries |
ENSG00000197323 |
|
esophageal adenocarcinoma |
missense_variant |
7.306% (32/438) |
1 entry |
ENSG00000197323 |
|
Thyroid Gland Oncocytic Follicular Carcinoma |
gene_fusion |
48.65% (36/74) |
1 entry |
ENSG00000197323 |
|
prostate adenocarcinoma |
sequence_alteration |
4.952% (72/1454) |
1 entry |
ENSG00000197323 |
|
Follicular Variant Thyroid Gland Papillary Carcinoma |
gene_fusion |
50.0% (13/26) |
1 entry |
ENSG00000197323 |
|
metaplastic breast carcinoma |
missense_variant |
5.882% (3/51) |
1 entry |
ENSG00000197323 |
|
colorectal adenocarcinoma |
frameshift_variant |
4.11% (48/1168) |
1 entry |
ENSG00000197323 |
|
melanoma |
conservative_inframe_deletion |
6.931% (7/101) |
1 entry |
ENSG00000197323 |
|
brain glioblastoma |
sequence_alteration |
1.404% (13/926) |
1 entry |
ENSG00000197323 |
|
non-small cell lung carcinoma |
missense_variant |
3.226% (2/62) |
2 entries |
ENSG00000197323 |
|
prostate carcinoma |
missense_variant |
2.479% (12/484) |
1 entry |
ENSG00000197323 |
|
squamous cell lung carcinoma |
missense_variant |
0.7212% (6/832) |
2 entries |
ENSG00000197323 |
|
HER2 Positive Breast Carcinoma |
sequence_alteration |
6.329% (10/158) |
1 entry |
ENSG00000197323 |
|
ovarian serous adenocarcinoma |
missense_variant |
0.2886% (2/693) |
1 entry |
ENSG00000197323 |
|
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma |
gene_fusion |
20.0% (2/10) |
1 entry |
ENSG00000197323 |
|
clear cell renal carcinoma |
sequence_alteration |
0.289% (4/1384) |
1 entry |
ENSG00000197323 |
|
colorectal adenocarcinoma |
missense_variant |
4.11% (48/1168) |
3 entries |
ENSG00000197323 |
|
chronic lymphocytic leukemia |
sequence_alteration |
0.3378% (3/888) |
1 entry |
ENSG00000197323 |
|
rectal adenocarcinoma |
missense_variant |
1.81% (4/221) |
2 entries |
ENSG00000197323 |
|
colon adenocarcinoma |
stop_gained |
2.523% (19/753) |
2 entries |
ENSG00000197323 |
|
lobular breast carcinoma |
sequence_alteration |
13.16% (5/38) |
1 entry |
ENSG00000197323 |
|
gastric adenocarcinoma |
missense_variant |
1.288% (9/699) |
1 entry |
ENSG00000197323 |
|
colorectal adenocarcinoma |
stop_gained |
4.11% (48/1168) |
1 entry |
ENSG00000197323 |
|
bladder carcinoma |
sequence_alteration |
1.081% (6/555) |
1 entry |
ENSG00000197323 |
|
pancreatic ductal adenocarcinoma |
missense_variant |
3.733% (47/1259) |
1 entry |
ENSG00000197323 |
|
prostate carcinoma |
sequence_alteration |
2.479% (12/484) |
1 entry |
ENSG00000197323 |
|
glioma |
missense_variant |
0.3407% (2/587) |
1 entry |
ENSG00000197323 |
|
colon adenocarcinoma |
frameshift_variant |
2.523% (19/753) |
1 entry |
ENSG00000197323 |
|
head and neck squamous cell carcinoma |
missense_variant |
0.3195% (2/626) |
1 entry |
ENSG00000197323 |
|
gastric intestinal type adenocarcinoma |
missense_variant |
3.529% (3/85) |
2 entries |
ENSG00000197323 |
|
cecum adenocarcinoma |
missense_variant |
1.527% (2/131) |
1 entry |
ENSG00000197323 |
|
lung adenocarcinoma |
missense_variant |
1.06% (13/1226) |
4 entries |
ENSG00000197323 |
|
melanoma |
missense_variant |
6.931% (7/101) |
2 entries |
ENSG00000197323 |
|
skin melanoma |
missense_variant |
0.8273% (8/967) |
2 entries |
ENSG00000197323 |
|
clear cell renal carcinoma |
missense_variant |
0.289% (4/1384) |
1 entry |
ENSG00000197323 |
|
colon adenocarcinoma |
sequence_alteration |
2.523% (19/753) |
2 entries |
ENSG00000197323 |
|
skin melanoma |
stop_gained |
0.8273% (8/967) |
2 entries |
ENSG00000197323 |
|
colorectal adenocarcinoma |
sequence_alteration |
4.11% (48/1168) |
1 entry |
ENSG00000197323 |
|
esophageal squamous cell carcinoma |
missense_variant |
0.5926% (4/675) |
2 entries |
ENSG00000197323 |
|
brain glioblastoma |
missense_variant |
1.404% (13/926) |
1 entry |
ENSG00000197323 |
|
small cell lung carcinoma |
missense_variant |
0.9288% (3/323) |
2 entries |
ENSG00000197323 |
|
colon adenocarcinoma |
missense_variant |
2.523% (19/753) |
3 entries |
ENSG00000197323 |
|
Ampulla of Vater Carcinoma |
missense_variant |
2.353% (2/85) |
1 entry |
ENSG00000197323 |
|
hepatocellular carcinoma |
missense_variant |
1.221% (11/901) |
1 entry |
ENSG00000197323 |
|
non-small cell lung carcinoma |
sequence_alteration |
3.226% (2/62) |
1 entry |
ENSG00000197323 |
|
anaplastic oligodendroglioma |
frameshift_variant |
2.381% (1/42) |
1 entry |
ENSG00000197323 |
|
basal cell carcinoma |
sequence_alteration |
3.448% (2/58) |
1 entry |
ENSG00000197323 |
|
gastric intestinal type adenocarcinoma |
frameshift_variant |
3.529% (3/85) |
1 entry |
ENSG00000197323 |
|
osteosarcoma |
frameshift_variant |
0.8621% (1/116) |
1 entry |
ENSG00000197323 |
|
adrenal cortex carcinoma |
missense_variant |
0.6098% (1/164) |
1 entry |
ENSG00000197323 |
|
Gallbladder Adenocarcinoma |
sequence_alteration |
1.149% (1/87) |
1 entry |
ENSG00000197323 |
|
neoplasm of mature B-cells |
missense_variant |
2.941% (1/34) |
1 entry |
ENSG00000197323 |
|
T-cell acute lymphoblastic leukemia |
amino_acid_insertion |
0.2632% (1/380) |
1 entry |
ENSG00000197323 |
|
colon carcinoma |
missense_variant |
12.5% (1/8) |
1 entry |
ENSG00000197323 |
|
chromophobe renal cell carcinoma |
frameshift_variant |
0.8547% (1/117) |
1 entry |
ENSG00000197323 |
|
HER2 Positive Breast Carcinoma |
missense_variant |
6.329% (10/158) |
1 entry |
ENSG00000197323 |
|
large cell lung carcinoma |
missense_variant |
4.167% (1/24) |
1 entry |
ENSG00000197323 |
|
lung adenocarcinoma |
frameshift_variant |
1.06% (13/1226) |
1 entry |
ENSG00000197323 |
|
oral squamous cell carcinoma |
missense_variant |
0.4878% (1/205) |
1 entry |
ENSG00000197323 |
|
colorectal adenocarcinoma |
amino_acid_insertion |
4.11% (48/1168) |
1 entry |
ENSG00000197323 |
|
central nervous system primitive neuroectodermal neoplasm |
frameshift_variant |
0.6757% (3/444) |
1 entry |
ENSG00000197323 |
|
Merkel cell skin cancer |
missense_variant |
3.333% (1/30) |
1 entry |
ENSG00000197323 |
|
basal cell carcinoma |
missense_variant |
3.448% (2/58) |
1 entry |
ENSG00000197323 |
|
diffuse large B-cell lymphoma |
missense_variant |
0.9868% (3/304) |
1 entry |
ENSG00000197323 |
|
nasopharyngeal squamous cell carcinoma |
missense_variant |
0.5988% (1/167) |
1 entry |
ENSG00000197323 |
|
female breast carcinoma |
frameshift_variant |
0.5115% (2/391) |
1 entry |
ENSG00000197323 |
|
Gallbladder Adenocarcinoma |
missense_variant |
1.149% (1/87) |
1 entry |
ENSG00000197323 |
|
chromophobe renal cell carcinoma |
sequence_alteration |
0.8547% (1/117) |
1 entry |
ENSG00000197323 |
|
small cell lung carcinoma |
sequence_alteration |
0.9288% (3/323) |
1 entry |
ENSG00000197323 |
|
skin carcinoma |
missense_variant |
7.692% (8/104) |
1 entry |
ENSG00000197323 |
|
ependymoma |
sequence_alteration |
2.174% (1/46) |
1 entry |
ENSG00000197323 |
|
female breast carcinoma |
missense_variant |
0.5115% (2/391) |
1 entry |
ENSG00000197323 |
|
Cortisol-Producing Adrenal Cortex Adenoma |
missense_variant |
0.8065% (1/124) |
1 entry |
ENSG00000197323 |
|
rectal adenocarcinoma |
conservative_inframe_deletion |
1.81% (4/221) |
1 entry |
ENSG00000197323 |
|
Mantle cell lymphoma |
missense_variant |
2.439% (1/41) |
1 entry |